By Catherine Eckford2024-08-12T21:24:09
The next-generation B-cell depletion biologic therapy has demonstrated promise in B-cell malignancies and autoimmune diseases.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-16T10:59:00Z
2026-06-15T07:55:00Z
Sponsored by Octave, By Adam Cross
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-04-14T12:29:00
Sponsored by JRS Pharma, In association with Vetter Pharma
2025-11-20T15:00:00
Sponsored by Rapid Micro Biosystems
2026-06-15T07:55:00
Sponsored by Octave, By Adam Cross
2026-04-29T14:00:00 2026-04-29T15:00:00
Sponsored by USP
Site powered by Webvision Cloud